Biological Drug Products – Development and Strategies
Autor W Wangen Limba Engleză Hardback – 28 noi 2013
Preț: 1176.88 lei
Preț vechi: 1238.82 lei
-5% Nou
Puncte Express: 1765
Preț estimativ în valută:
225.21€ • 235.43$ • 190.31£
225.21€ • 235.43$ • 190.31£
Carte tipărită la comandă
Livrare economică 06-20 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781118148891
ISBN-10: 1118148894
Pagini: 744
Dimensiuni: 156 x 234 x 41 mm
Greutate: 1.12 kg
Ediția:New.
Editura: Wiley
Locul publicării:Hoboken, United States
ISBN-10: 1118148894
Pagini: 744
Dimensiuni: 156 x 234 x 41 mm
Greutate: 1.12 kg
Ediția:New.
Editura: Wiley
Locul publicării:Hoboken, United States
Public țintă
Pharmaceutical and biotech scientists, pharmacologists, medicinal chemists, formulations scientists Biological and biochemical engineers, protein scientists, molecular biologists, toxicologists, clinical researchersGovernment regulatory bodies FDA (USA), EMEA (Europe), PMDA (Japan), NICPBP (China) and equivalent agencies
Academic biotechnology, drug development, pharmaceutical, and pharmacy programs
Cuprins
Notă biografică
WEI WANG, PhD, is a Research Fellow for Pfizer BioTherapeutics Pharmaceutical Sciences. In addition, Dr. Wang is Adjunct Professor in the School of Pharmacy and Health Sciences at the University of the Pacific. MANMOHAN SINGH, PhD, is Head of Technical Development at Novartis Vaccines and Diagnostics. Dr. Singh has authored over 120 peer-reviewed manuscripts, reviews, and book chapters in the area of vaccine formulations and adjuvant research. He is also an Adjunct Professor at the Eshelman School of Pharmacy at University of North Carolina, Chapel Hill.
Descriere
This book overviews the fundamental aspects, challenges, and strategies for developing a variety of biological drugs -- a large and growing segment of the pharmaceutical industry. Contributing authors discuss the development process, safety and clinical assessments, manufacturing, regulatory and intellectual property issues.